Lipoprotein (a) in Ischemic Heart Disease and Cerebrovascular Disease
نویسندگان
چکیده
منابع مشابه
Lipoprotein (a) in ischemic heart disease and cerebrovascular disease.
Lipoprotein (a) [Lp(a)] was first described by Berg as a genetic variant of low density lipoprotein (LDL) more than twenty-five years ago (1). Lp(a) lipid composition is similar to that of LDL, and floats in a density range of 1.051.125g/ml. Its protein moiety contains a specific glycoprotein, apolipoprotein (a) [apo(a)], in addition to apo B-100. Recently, the cDNA sequence of human apo(a) was...
متن کاملLipoprotein(a) and ischemic cerebrovascular disease in young adults.
BACKGROUND AND PURPOSE Serum lipoprotein(a) level is genetically determined and remains almost constant throughout life. Based on this property, we investigated the serum lipoprotein(a) levels of ischemic stroke patients in the chronic stage (mean period after stroke, 27 months) and its relation to the types of ischemic stroke. METHODS We measured serum lipoprotein(a) levels in 101 patients w...
متن کاملMortality from Ischemic Heart Disease and Cerebrovascular Disease in
Age standardized mortality data from Ischemic heart disease (IHD) and Cerebrovascular disease (CVD) for the population of Israel were analyzed for the years 1969 to 1978. There has been a clear fall in mortality from both diseases over this period that has been more pronounced in relation to CVD. The mortality from IHD is considerably higher in the total population and in each of the ethnic gro...
متن کاملتاثیر آلوپورینول بر رویoutcome بیماران ischemic heart disease بستری در ccu
چکیده مقدمه: بیماری های ایسکمیک قلب با ویژگی کاهش خون رسانی به ماهیچه قلب، به علت بیماری های عروق کرونر از جمله آترواسکلروز ایجاد می شود. از افزایش فعالیت گزانتین اکسیداز نیز منجر به عدم کارایی عروق در خون رسانی به عضله ی قلب و ایجاد انواع ایسکمی و آسیبهای بافتی و عروقی می شود. به نظر می رسد، داروهای مهارکننده گزانتین اکسیداز از طریق افزایش شرب بافتی در بهبود علائم بیماری های ایسکمیک قلب موثر ...
Causes of readmission in ischemic heart disease patients
Introduction: Ischemic heart diseases are the most prevalent causes of diseases in hospitals and are the second cause of mortality in Iran. Treatment cost for most of these preventable causes of readmission is remarkably high. This study is designed to investigate the readmission causes of ischemic heart diseases in Bandar Abbas. Methods: In this descriptive study, during a 6 month period, al...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Atherosclerosis and Thrombosis
سال: 1995
ISSN: 1340-3478,1880-3873
DOI: 10.5551/jat1994.2.supplement1_s13